CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Crispr Therapeutics AG (CRSP) stock saw a decline, ending the day at $38.85 which represents a decrease of $-0.84 or -2.12% from the prior close of $39.69. The stock opened at $39.06 and touched a low ...

If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...

The bitter cold is sticking around through Wednesday in Kansas City. Temperatures will rise above freezing at the end of the ...

Tesla stock was up in early trading Tuesday, following a strong Monday finish, but gains faded late in the day. Despite daily ...

If you're interested in broad exposure to the Large Cap Growth segment of the US equity market, look no further than the Vanguard Growth ETF (VUG), a passively managed exchange traded fund launched on ...

The Vanguard US Total Market Shares Index ETF (ASX: VTS) outperformed the Vanguard Australian Shares Index ETF (ASX: VAS) by ...

As market-capitalization-weighted index ETFs, both VOO and VTI naturally feature a high allocation to large-cap stocks. If ...

Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) is a smart beta exchange traded fund launched on ...

His influence is partly the result of a very online political establishment, and partly thanks to a right-leaning media that is hostile to Keir Starmer’s Labour government. By Mark Landler The ...